Market Overview

Carter Worth And Mike Khouw's Bristol-Myers Squibb Options Trade


On CNBC's "Options Action," Carter Worth spoke about price action in Bristol-Myers Squibb Co (NYSE: BMY).

He showed on the chart that Bristol-Myers has been underperforming Health Care SPDR (NYSE: XLV) since 2016, but in the last two months it's performing better than the sector. Worth thinks that at minimum, the stock could return to trend and trade higher to $55.

Khouw suggested that investors should buy the Dec. $50 call in Bristol-Myers for $2.50. The trade breaks even at $52.50 or 3.37% above the current stock price.

Posted-In: Carter Worth CNBC Mike Khouw Options ActionOptions Markets Media


Related Articles (XLV + BMY)

View Comments and Join the Discussion!
Lightning Fast
Market News Service
$199 Free 14 Day Trial
Book A Demo
Learn How You Can Succeed In The Market With Benzinga Pro

Fastest Market News

Real-Time News Alerts

Customizable News Filters

Book A Demo

FreightWaves Oil Report: Refining Capacity Is Good For Truckers, And It's Rising

Ocean Shipping On Wall Street: The Sound Of Silence